PT Pyridam Farma Tbk
IDX:PYFA 株式レポート
Pyridam Farma マネジメント 主要情報 CEO給与比率 n/a CEO在任期間 4.3yrs CEOの所有権 n/a 経営陣の平均在職期間 4yrs 取締役会の平均在任期間 4.3yrs
経営陣の近況
PT Pyridam Farma Tbk, Annual General Meeting, Jun 25, 2024 May 21
No independent directors Nov 16
Less than half of directors are independent Apr 27
すべての更新を表示
Third quarter 2024 earnings released: Rp10.72 loss per share (vs Rp16.47 loss in 3Q 2023) Nov 03
New minor risk - Financial data availability Oct 01
PT Pyridam Farma Tbk, Annual General Meeting, Jun 25, 2024 May 21
New major risk - Shareholder dilution May 17
New major risk - Market cap size Apr 22
Full year 2023 earnings released: Rp159 loss per share (vs Rp515 profit in FY 2022) Mar 16
PT Pyridam Farma Tbk has filed a Follow-on Equity Offering. Jan 11 PT Pyridam Farma Tbk has filed a Follow-on Equity Offering. Jan 10
PT Pyridam Farma Tbk has filed a Follow-on Equity Offering. Jan 09
New minor risk - Share price stability Nov 29
Second quarter 2023 earnings released: Rp45.55 loss per share (vs Rp12.25 profit in 2Q 2022) Aug 06
New minor risk - Share price stability Jun 20
First quarter 2023 earnings released: Rp23.01 loss per share (vs Rp4.67 profit in 1Q 2022) May 08
Full year 2022 earnings released Apr 08
No independent directors Nov 16
Second quarter 2022 earnings released: EPS: Rp12.25 (vs Rp0.96 in 2Q 2021) Sep 05
Less than half of directors are independent Apr 27
PT Pyridam Farma Tbk (IDX:PYFA) entred into an agreement to acquire PT Holi Pharma from Erik Darius Mardiwidyo and Murtiati. Aug 28
Investor sentiment improved over the past week Jul 14
Full year 2020 earnings released: EPS Rp41.31 (vs Rp17.46 in FY 2019) Jul 04
Investor sentiment improved over the past week Jun 21
Investor sentiment improved over the past week Apr 30
Investor sentiment deteriorated over the past week Jan 18
Investor sentiment improved over the past week Jan 11
New 90-day high: Rp1,340 Jan 11
Investor sentiment improved over the past week Jan 05
Investor sentiment deteriorated over the past week Dec 15
Market bids up stock over the past week Dec 08
New 90-day high: Rp1,150 Dec 08
Third quarter 2020 earnings released: EPS Rp19.49 Nov 08
Market bids up stock over the past week Oct 15
PT Pyridam Internasional Corporation acquired additional 29.96% stake in PT Pyridam Farma Tbk (IDX:PYFA) from Hasan Tjandra, Indrawati Kosasih and Lindia Kosasih for approximately IDR 120 billion. Aug 04
CEO(最高経営責任者 Mr. Yan Gwan Lee serves as President Director at PT Pyridam Farma Tbk since August 14, 2020. He is a senior executive based in Indonesia and Singapore with working experience. He has several work experienc ... Show more
リーダーシップ・チーム 名称 ポジション 在職期間 報酬 所有権 President Director 4.3yrs データなし データなし CFO & Director no data データなし データなし COO, Head of Pharmacovigilance & Director no data データなし データなし Finance no data データなし データなし Head of Legal & Corporate Secretary 4yrs データなし データなし HRD Manager no data データなし データなし Head of OTC no data データなし データなし Head of Internal Audit Unit 3yrs データなし データなし
もっと見る
経験豊富な経営陣: PYFAの経営陣は 経験豊富 であると考えられます ( 4年の平均在職年数)。
取締役 名称 ポジション 在職期間 報酬 所有権 President Director 4.3yrs データなし データなし CFO & Director 4.3yrs データなし データなし COO, Head of Pharmacovigilance & Director 5.5yrs データなし データなし Independent Commissioner 9.5yrs データなし データなし President Commissioner 4.3yrs データなし データなし Independent Commissioner 2.7yrs データなし データなし Independent Commissioner 2.7yrs データなし データなし Director 1.4yrs データなし 0.0060% IDR 215.8m
もっと見る
経験豊富なボード: PYFAの 取締役会 は 経験豊富 であると考えられます ( 4.3年の平均在任期間)。
Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}